跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xtracee Plus® Ct - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xtracee Plus® Ct
Approved
STANDARD
Xtracee Plus® Ct
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
92c34a0586053ef0
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
92c34a0586053ef0
Drug Approval Philippines Name
Xtracee Plus® Ct
Product Name
Xtracee Plus® Ct
Registration Number
DRP-13671
Brand Name
Xtracee Plus® Ct
Generic Name
Ascorbic Acid + Zinc
Dosage Form
Chewable Tablet
Dosage Strength
250 mg (equivalent to 281.25 mg Sodium Ascorbate)/ 5 mg (equivalent to 35 mg Zinc Gluconate)
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Trader
Philippines
Issuance Date
24 March 2023
Expiry Date
24 March 2028
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
92c34a0586053ef0
Type
Standard
Back to Philippines FDA Approvals